UPDATE : Thursday, September 19, 2019
상단여백
Invossa inventor sold Kolon shares at highest value by Jeong Sae-im 2019-06-03 14:52
Until when will Kolon keep lying about Invossa? by Jeong Sae-im 2019-05-31 14:59
Samsung BioLogics agrees to manufacture CytoDyn’s HIV drug by Jeong Sae-im 2019-05-31 14:59
Announcement of Invossa license revocation was ‘procedural breach’: Kolon by Jeong Sae-im 2019-05-30 13:28
‘MDM2 gene’ may be associated with hyperprogression after immunotherapy by Kim Yun-mi 2019-05-29 12:35
라인
Invossa poses almost no safety threat: regulator by Lee Hye-seon 2019-05-28 16:02
Brazil OKs Samsung Bioepis’ trastuzumab biosimilar by Lee Han-soo 2019-05-27 15:52
‘Shareholders can surely win lawsuit against Kolon’ by Jeong Sae-im 2019-05-24 19:34
‘Kolon’s extra data insufficient to explain Invossa mislabeling’ by Lee Hye-seon 2019-05-23 14:51
Prosecutors seek arrest warrant of Samsung BioLogics CEO by Lee Han-soo 2019-05-23 11:19
라인
[News Focus] Kolon, regulator rapped for not doing enough to quell concerns of patients by Jeong Sae-im 2019-05-22 11:59
Legislator, activists call for revoking Invossa license, conducting probes by Jeong Sae-im 2019-05-21 16:03
Kolon to follow 3,700 Invossa-treated patients for 15 years by Jeong Sae-im 2019-05-17 15:38
Will Celltrion CEO’s bet on ‘bio valley’ pay off? by Jeong Sae-im 2019-05-17 13:21
CHA Biotech’s operating income plunges 92% in Q1 by Jeong Sae-im 2019-05-16 13:41
라인
KangStem Biotech completes stem cell drug plant by Jeong Sae-im 2019-05-16 11:27
Samsung BioLogics in tight spot amid probe, shareholders’ lawsuit by Jeong Sae-im 2019-05-14 14:10
Celltrion’s operating income down 33% in Q1 by Jeong Sae-im 2019-05-09 15:26
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma by Jeong Sae-im 2019-05-08 15:33
Inspection will clear all suspicions over Invossa: TissueGene by Jeong Sae-im 2019-05-08 14:32
여백
여백
여백
Back to Top